Symposium | Early intervention and use of ECP combinations in cGvHD

Florent Malard, Hôpital Saint-Antoine and Sorbonne Université, Paris, FR, delivered a presentation during the GvHD symposium at the...

Symposium | ECP for chronic GvHD: Patient eligibility, treatment optimization, and follow-up

Here, we share a presentation by Zinaida Perić, University of Rijeka, Rijeka, HR, as part of the GvHD...

Symposium | The long-term burden of cGvHD

During the GvHD symposium at the 50th Annual Meeting of the EBMT, Bipin Savani, Vanderbilt University Medical Center, Nashville, US, explored the long-term...

Symposium | A brief overview and history of ECP

The GvHD Hub symposium at the 50th Annual Meeting of the EBMT was chaired by Mohamad Mohty, and featured presentations by Florent Malard, Zinaida Perić,...

PTCy-based GvHD prophylaxis following MMUD peripheral blood stem cell transplantation: Results from the phase II ACCESS trial

We summarize results from the phase II ACCESS trial of PTCy-based GvHD...

Belumosudil in Japanese patients with cGvHD: Results from a phase III trial

Here, we summarize results from a phase III trial of belumosudil as a second or subsequent line of therapy in Japanese...

An update of Italian best practice recommendations for ECP use in GvHD

Following the publication of additional ECP studies, and updates to the EBMT consensus recommendation, the SIdEM and GITMO...

ECP for the treatment of cGvHD: Emerging data and clinical management considerations

In cGvHD, immunosuppressant corticosteroids remain a first-line treatment option. ECP is recommended as a...

 Future perspectives of ECP for GvHD treatment

The GvHD Hub were pleased to speak to Andrew Gennery, Newcastle University and Great North Children’s Hospital, UK, and Chair of the UK Photopheresis...

Symposium | Early intervention and use of ECP combinations in cGvHD

Florent Malard, Hôpital Saint-Antoine and Sorbonne Université, Paris, FR, delivered a presentation during the GvHD symposium at the...